The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer

British Journal of Oral and Maxillofacial Surgery

Volumn 49, Issue 6, 2011, Pages 423-429

  Shaw, Richard ^a,b   Robinson, Max ^c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Clinical trials; HPV; Oropharyngeal cancer; Prognostic biomarker

Indexed keywords

CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; PROTEIN E6; PROTEIN E7; PROTEIN P53; TUMOR MARKER; WART VIRUS VACCINE;

ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; VIRUS CULTURE; VIRUS DETECTION;

CARCINOMA, SQUAMOUS CELL; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052025654     PISSN: 02664356     EISSN: 15321940     Source Type: Journal    
DOI: 10.1016/j.bjoms.2010.06.023     Document Type: Article

References (49)

1. H. zur Hausen The search for infectious causes of human cancers: where and why (Nobel lecture) Angew Chem Int Ed Engl 48 2009 5798 5808
2. V. Bouvard, R. Baan, K. Straif, Y. Grosse, B. Secretan, and F. El Ghissassi A review of human carcinogens - Part B: biological agents Lancet Oncol 10 2009 321 322
3. A.K. Chaturvedi, E.A. Engels, W.F. Anderson, and M.L. Gillison Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 2008 612 619 (Pubitemid 351264356)
4. A.R. Kreimer, G.M. Clifford, P. Boyle, and S. Franceschi Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review Cancer Epidemiol Biomarkers Prev 14 2005 467 475 (Pubitemid 40270113)
5. A. Nasman, P. Attner, L. Hammarstedt, J. Du, M. Eriksson, and G. Giraud Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125 2009 362 366
6. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
7. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, and L. Wu Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720 (Pubitemid 30365531)
8. C.C. Ragin, and E. Taioli Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis Int J Cancer 121 2007 1813 1820 (Pubitemid 47417302)
9. M. De Petrini, M. Ritta, M. Schena, L. Chiusa, P. Campisi, and C. Giordano Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression New Microbiol 29 2006 25 33
10. S. Friesland, H. Mellin, E. Munck-Wikland, A. Nilsson, J. Lindholm, and T. Dalianis Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma - relation to radiotherapy response and survival Anticancer Res 21 2001 529 534 (Pubitemid 32267566)
11. L. Licitra, F. Perrone, P. Bossi, S. Suardi, L. Mariani, and R. Artusi High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma J Clin Oncol 24 2006 5630 5636 (Pubitemid 46631302)
12. N. Reimers, H.U. Kasper, S.J. Weissenborn, H. Stutzer, S.F. Preuss, and T.K. Hoffmann Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738 (Pubitemid 46399359)
13. W. Li, C.H. Thompson, C.J. O'Brien, E.B. McNeil, R.A. Scolyer, and Y.E. Cossart Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil Int J Cancer 106 2003 553 558 (Pubitemid 36966212)
14. H. Mellin, S. Friesland, R. Lewensohn, T. Dalianis, and E. Munck-Wikland Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival Int J Cancer 89 2000 300 304 (Pubitemid 30430748)
15. S.E. Strome, A. Savva, A.E. Brissett, B.S. Gostout, J. Lewis, and A.C. Clayton Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations Clin Cancer Res 8 2002 1093 1100 (Pubitemid 35177361)
16. C. Wittekindt, E. Gültekin, S.J. Weissenborn, H.P. Dienes, H.J. Pfister, and J.P. Klussmann Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival Adv Otorhinolaryngol 62 2005 72 80
17. M. Robinson, P. Sloan, and R.J. Shaw Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing Oral Oncol 46 7 2010 492 496
18. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269 (Pubitemid 351480538)
19. B. Kumar, K.G. Cordell, J.S. Lee, F.P. Worden, M.E. Prince, and H.H. Tran EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
20. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010 [Epub ahead of print PMID 20530316].
21. P.M. Weinberger, Z. Yu, B.G. Haffty, D. Kowalski, M. Harigopal, and J. Brandsma Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 2006 736 747 (Pubitemid 46622040)
22. D. Lindquist, M. Romanitan, L. Hammarstedt, A. Nasman, H. Dahlstrand, and J. Lindholm Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 Mol Oncol 1 2007 350 355 (Pubitemid 350186274)
23. L. Charfi, T. Jouffroy, and P. de Cremoux Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome Cancer Lett 260 2008 72 78
24. H.C. Hafkamp, J.J. Manni, and A. Haesevoets Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas Int J Cancer 122 2008 2656 2664 (Pubitemid 351631366)
25. A.C. Nichols, W.C. Faquin, W.H. Westra, E.A. Mroz, S. Begum, and J.R. Clark HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma Otolaryngol Head Neck Surg 140 2009 228 234
26. A.R. Sedaghat, Z. Zhang, S. Begum, R. Palermo, S. Best, and K.M. Ulmer Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas Laryngoscope 119 2009 1542 1549
27. A. Luginbuhl, M. Sanders, and J.D. Spiro Prevalence, morphology, and prognosis of human papillomavirus in tonsillar cancer Ann Otol Rhinol Laryngol 118 2009 742 749
28. J.P. Klussmann, J.J. Mooren, and M. Lehnen Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications Clin Cancer Res 15 2009 1779 1786
29. J.T. Rich, S. Milov, J.S. Lewis Jr. , W.L. Thorstad, D.R. Adkins, and B.H. Haughey Transoral laser microsurgery (TLM)+/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors Laryngoscope 119 2009 1709 1719
30. C.A. Fischer, I. Zlobec, and E. Green Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer 126 2010 1256 1262
31. K. Hannisdal, A. Schjølberg, P.M. De Angelis, M. Boysen, and O.P. Clausen Human papillomavirus (HPV)-positive tonsillar carcinomas are frequent and have a favourable prognosis in males in Norway Acta Otolaryngol 130 2010 293 299
32. R.M. Simon, S. Paik, and D.F. Hayes Use of archived specimens in evaluation of prognostic and predictive biomarkers J Natl Cancer Inst 101 2009 1446 1452
33. S.M. Wilting, S.J. Smeets, and P.J. Snijders Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck BMC Med Genomics 2 2009 32
34. S.S. Chang, and J. Califano Current status of biomarkers in head and neck cancer J Surg Oncol 97 2008 640 643 (Pubitemid 351812962)
35. S.N. Rogers, J.S. Brown, and J.A. Woolgar Survival following primary surgery for oral cancer Oral Oncol 45 2009 201 211
36. R.J. Shaw, D. Lowe, J.A. Woolgar, J.S. Brown, E.D. Vaughan, and C. Evans Extracapsular spread in oral squamous cell carcinoma Head Neck 32 6 2009 714 722
37. L.H. Sobin, and Ch. Wittekind International Union Against Cancer: TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
38. S. Tandon, C. Tudur-Smith, R.D. Riley, M.T. Boyd, and T.M. Jones A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck Cancer Epidemiol Biomarkers Prev 19 2010 574 587
39. S.C. Fausch, L.M. Fahey, D.M. Da Silva, and W.M. Kast Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation J Immunol 174 2005 7172 7178 (Pubitemid 40705684)
40. P.C. Maciag, S. Radulovic, and J. Rothman The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Vaccine 27 2009 3975 3983
41. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
42. J.B. Vermorken, E. Remenar, and C. van Herpen Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704 (Pubitemid 350005151)
43. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
44. G. D'Souza, A.R. Kreimer, and R. Viscidi Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956 (Pubitemid 46740304)
45. B.G. Hansson, K. Rosenquist, and A. Antonsson Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden Acta Otolaryngol 125 2005 1337 1344 (Pubitemid 41722001)
46. R. Haddad, C. Crum, and Z. Chen HPV16 transmission between a couple with HPV-related head and neck cancer Oral Oncol 44 2008 812 815 (Pubitemid 351992917)
47. A.Y. Chuang, T.C. Chuang, and S. Chang Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma Oral Oncol 44 2008 915 919
48. K. Settle, M.R. Posner, and L.M. Schumaker Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients Cancer Prev Res (Phila PA) 2 2009 776 781
49. R. Herrero, X. Castellsagué, and M. Pawlita Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 2003 1772 1783 (Pubitemid 38008900)